Hematopoietic stem cells: From the bone to the bioreactor

Trends in Biotechnology

Volumn 21, Issue 5, 2003, Pages 233-240

  Cabrita, Gonçalo J M ^a   Ferreira, Bruno S ^a   Lobato Da Silva, Cláudia ^a   Gonçalves, Raquel ^a   Almeida Porada, Graça ^b   Cabral, Joaquim M S ^a  

^a INSTITUTO SUPERIOR TÉCNICO   (Portugal)

^b UNIVERSITY OF NEVADA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOREACTORS; BONE; CELLS;

STEM CELLS;

BIOMEDICAL ENGINEERING;

BIOTECHNOLOGY;

BIOMEDICINE; BIOREACTOR; CELL CULTURE; CELL DIFFERENTIATION; CELL HETEROGENEITY; CELL POPULATION; CELL PROLIFERATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; IN VITRO STUDY; PLASTICITY; PRIORITY JOURNAL; REVIEW;

EID: 0037408143     PISSN: 01677799     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-7799(03)00076-3     Document Type: Review

References (69)

1. Reya T., et al. Stem cells, cancer, and cancer stem cells. Nature. 414:2001;105-111.
2. Ema H., et al. In vitro self-renewal division of hematopoietic stem cells. J. Exp. Med. 192:2000;1281-1288.
3. Fox N., et al. Thrombopoietin expands hematopoietic stem cells after transplantation. J. Clin. Invest. 110:2002;389-394.
4. Audet J., et al. Distinct role of gp130 activation in promoting self-renewal divisions by mitogenically stimulated murine hematopoietic stem cells. Proc. Natl. Acad. Sci. U. S. A. 98:2001;1757-1762.
5. Gollner G., et al. Regulatory elements of the leukaemia inhibitory factor (LIF) promoter in murine bone marrow stromal cells. Cytokine. 11:1999;656-663.
6. Watt S.M., Chan J.Y. CD164 - a novel sialomucin on CD34+ cells. Leuk. Lymphoma. 37:2000;1-25.
7. Dao M.A., Nolta J.A. CD34: to select or not to select? That is the question. Leukemia. 14:2000;773-776.
8. Zhu J., Emerson S.G. Hematopoietic cytokines, transcription factors and lineage commitment. Oncogene. 21:2002;3295-3313.
9. Poulsom R., et al. Adult stem cell plasticity. J. Pathol. 197:2002;441-456.
10. Ying Q.L., et al. Changing potency by spontaneous fusion. Nature. 416:2002;545-548.
11. Orkin S.H., Zon L.I. Hematopoiesis and stem cells: plasticity versus developmental heterogeneity. Nat. Immun. 3:2002;323-328.
12. Tsai R.Y., et al. Plasticity, niches, and the use of stem cells. Dev. Cell. 2:2002;707-712.
13. McDowell C.L., Papoutsakis E.T. Serum increases the CD13 receptor expression, reduces the transduction of fluid-mechanical forces, and alters the metabolism of HL60 cells cultured in agitated bioreactors. Biotechnol. Bioeng. 60:1998;259-268.
14. Sandstrom C.E., et al. Review: serum-free media for cultures of primitive and mature hematopoietic cells. Biotechnol. Bioeng. 43:1994;706-733.
15. Almeida-Porada G., et al. Evaluation of serum-free culture conditions able to support the ex vivo expansion and engraftment of human hematopoietic stem cells in the human-to-sheep xenograft model. J. Hematother. Stem Cell Res. 9:2000;683-693.
16. Knaan-Shanzer S., et al. Intrinsic potential of phenotypically defined human hemopoietic stem cells to self-renew in short-term in vitro cultures. Exp. Hematol. 27:1999;1440-1450.
17. Zandstra P.W., et al. Concentration-dependent internalization of a cytokine/cytokine receptor complex in human hematopoietic cells. Biotechnol. Bioeng. 63:1999;493-501.
18. Breems D.A., et al. Stroma-contact prevents loss of hematopoietic stem cell quality during ex vivo expansion of CD34+ mobilized peripheral blood stem cells. Blood. 91:1998;111-117.
19. Kohler T., et al. Defining optimum conditions for the ex vivo expansion of human umbilical cord blood cells. Influences of progenitor enrichment, interference with feeder layers, early-acting cytokines and agitation of culture vessels. Stem Cells. 17:1999;19-24.
20. Madlambayan G.J., et al. Controlling culture dynamics for the expansion of hematopoietic stem cells. J. Hematother. Stem Cell Res. 10:2001;481-492.
21. Mostafa S.S., et al. Oxygen tension modulates the expression of cytokine receptors, transcription factors, and lineage-specific markers in cultured human megakaryocytes. Exp. Hematol. 29:2001;873-883.
22. Zandstra P.W., Nagy A. Stem cell bioengineering. Annu. Rev. Biomed. Eng. 3:2001;275-305.
23. Ramirez-Bergeron D.L., Simon M.C. Hypoxia-inducible factor and the development of stem cells of the cardiovascular system. Stem Cells. 19:2001;279-286.
24. Yang H., et al. Higher pH promotes megakaryocytic maturation and apoptosis. Stem Cells. 20:2002;320-328.
25. Nielsen L.K. Bioreactors for hematopoietic cell culture. Annu. Rev. Biomed. Eng. 1:1999;129-152.
26. Dexter T.M., et al. Stimulation of differentiation and proliferation of haemopoietic cells in vitro. J. Cell. Physiol. 82:1973;461-473.
27. Collins P.C., et al. Stirred culture of peripheral and cord blood hematopoietic cells offers advantages over traditional static systems for clinically relevant applications. Biotechnol. Bioeng. 59:1998;534-543.
28. Cabral J.M.S. Ex vivo expansion of hematopoietic stem cells in bioreactors. Biotechnol. Lett. 23:2001;741-751.
29. Palsson B.O., et al. Expansion of human bone marrow progenitor cells in a high cell density continuous perfusion system. Biotechnology (NY). 11:1993;368-372.
30. Koller M.R., et al. Expansion of primitive human hematopoietic progenitors in a perfusion bioreactor system with IL-3, IL-6, and stem cell factor. Biotechnology (NY). 11:1993;358-363.
31. Koller M.R., et al. Large-scale expansion of human stem and progenitor cells from bone marrow mononuclear cells in continuous perfusion cultures. Blood. 82:1993;378-384.
32. Schwartz R.M., et al. Rapid medium perfusion rate significantly increases the productivity and longevity of human bone marrow cultures. Proc. Natl. Acad. Sci. U. S. A. 88:1991;6760-6764.
33. Oh D.J., et al. Frequent harvesting from perfused bone marrow cultures results in increased overall cell and progenitor expansion. Biotechnol. Bioeng. 44:1994;609-616.
34. Palsson, B.Ø. et al. (1995) Device for maintaining and growing human stem and/or hematopoietic cells. Patent US 5,459,069.
35. Palsson, B.Ø. et al. (1997) Bioreactor for mammalian cell growth and maintenance. Patent US 5,688,687.
36. Chabannon C., et al. Production of ex vivo expanded hematopoietic cells and progenitors in a closed bioreactor, starting with a small volume marrow collection: a feasibility study in patients with poor-risk breast cancer and receiving high-doses of cyclophosphamide. Int. J. Oncol. 15:1999;511-518.
37. Peng C.-A., Palsson B.O. Cell growth and differentiation on feeder layers is predicted to be influenced by bioreactor geometry. Biotechnol. Bioeng. 50:1996;479-492.
38. Sandstrom C.E., et al. Development of novel perfusion chamber to retain nonadherent cells and its use for comparison of human 'mobilized' peripheral blood mononuclear cell cultures with and without irradiated bone marrow stroma. Biotechnol. Bioeng. 50:1996;493-504.
39. Sardonini C.A., Wu Y.J. Expansion and differentiation of human hematopoietic cells from static cultures through small-scale bioreactors. Biotechnol. Prog. 9:1993;131-137.
40. Zandstra P.W., et al. Expansion of hematopoietic progenitor cell populations in stirred suspension bioreactors of normal human bone marrow cells. Biotechnology (NY). 12:1994;909-914.
41. Levee M.G., et al. Microencapsulated human bone marrow cultures: a potential culture system for the clonal outgrowth of hematopoietic progenitor cells. Biotechnol. Bioeng. 43:1994;734-739.
42. McDowell C.L., Papoutsakis E.T. Increased agitation intensity increases CD13 receptor surface content and mRNA levels, and alters the metabolism of HL60 cells cultured in stirred tank bioreactors. Biotechnol. Bioeng. 60:1998;239-250.
43. Kawada H., et al. Rapid ex vivo expansion of human umbilical cord hematopoietic progenitors using a novel culture system. Exp. Hematol. 27:1999;904-915.
44. Wang T.Y., et al. Multilineal hematopoiesis in a three-dimensional murine long-term bone marrow culture. Exp. Hematol. 23:1995;26-32.
45. Highfill J.G., et al. Large-scale production of murine bone marrow cells in an airlift packed bed bioreactor. Biotechnol. Bioeng. 50:1996;514-520.
46. Mantalaris A., et al. Engineering a human bone marrow model: a case study on ex vivo erythropoiesis. Biotechnol. Prog. 14:1998;126-133.
47. Meissner P., et al. Development of a fixed bed bioreactor for the expansion of human hematopoietic progenitor cells. Cytotechnology. 30:1999;227-234.
48. Jelinek N., et al. Novel bioreactors for the ex vivo cultivation of hematopoietic cells. Eng. Life Sci. 2:2002;15-18.
49. Jelinek N., et al. A novel minimized fixed-bed cultivation system for hematopoietic cells. Exp. Hematol. 28:2000;122-123.
50. Ingram M., et al. Three-dimensional growth patterns of various human tumor cell lines in simulated microgravity of a NASA bioreactor. In Vitro Cell. Dev. Biol. Anim. 33:1997;459-466.
51. Collins P.C., et al. Real-time method for determining the colony-forming cell content of human hematopoietic cell cultures. Biotechnol. Bioeng. 55:1997;693-700.
52. Hevehan D.L., et al. Dynamic model of ex vivo granulocytic kinetics to examine the effects of oxygen tension, pH, and interleukin-3. Exp. Hematol. 28:2000;1016-1028.
53. Yang H., et al. Model-based estimation of myeloid hematopoietic progenitor cells in ex vivo cultures for cell and gene therapies. Biotechnol. Bioeng. 72:2001;144-155.
54. Lobato da Silva, C. et al. Modelling of ex vivo expansion/maintenance of hematopoietic stem cells. Bioprocess Biosyst. Eng. (in press) DOI: 10.1007/s00449-002-0307-7.
55. Geissler K., Wagner T. Cytokine combinations for the in vivo and ex vivo expansion of hematopoietic progenitor cells. Acta Med. Austriaca. 27:2000;21-24.
56. Li K., et al. Effects of flt-3 ligand in combination with TPO on the expansion of megakaryocytic progenitors. Cell Transplant. 9:2000;125-131.
57. Lazzari L., et al. Long-term expansion and maintenance of cord blood haematopoietic stem cells using thrombopoietin, Flt3-ligand, interleukin (IL)-6 and IL-11 in a serum-free and stroma-free culture system. Br. J. Haematol. 112:2001;397-404.
58. Shaw P.H., et al. Expansion of megakaryocyte precursors and stem cells from umbilical cord blood CD34+ cells in collagen and liquid culture media. J. Hematother. Stem Cell Res. 10:2001;391-403.
59. Su R.J., et al. Platelet-derived growth factor promotes ex vivo expansion of CD34+ cells from human cord blood and enhances long-term culture-initiating cells, non-obese diabetic/severe combined immunodeficient repopulating cells and formation of adherent cells. Br. J. Haematol. 117:2002;735-746.
60. Moore, M.A.(2002) Cytokine and chemokine networks influencing stem cell proliferation, differentiation, and marrow homing. J. Cell. Biochem. (Suppl. 38) 29-38.
61. Feugier P., et al. Ex vivo expansion of stem and progenitor cells in co-culture of mobilized peripheral blood CD34+ cells on human endothelium transfected with adenovectors expressing thrombopoietin, c-kit ligand, and Flt-3 ligand. J. Hematother. Stem Cell Res. 11:2002;127-138.
62. Ivanovic Z., et al. Primitive human HPCs are better maintained and expanded in vitro at 1 percent oxygen than at 20 percent. Transfusion. 40:2000;1482-1488.
63. Keil F., et al. Ex vivo expansion of long-term culture initiating marrow cells by IL-10, SCF, and IL-3. Transfusion. 42:2002;581-587.
64. Kimura T., et al. Signal through gp130 activated by soluble interleukin (IL)-6 receptor (R) and IL-6 or IL-6R/IL-6 fusion protein enhances ex vivo expansion of human peripheral blood-derived hematopoietic progenitors. Stem Cells. 18:2000;444-452.
65. Nakahata T. Ex vivo expansion of human hematopoietic stem cells. Int. J. Hematol. 73:2001;6-13.
66. Wagner T., et al. IL-10 increases the number of CFU-GM generated by ex vivo expansion of unmanipulated human MNCs and selected CD34+ cells. Transfusion. 41:2001;659-666.
67. Karanu F.N., et al. The notch ligand jagged-1 represents a novel growth factor of human hematopoietic stem cells. J. Exp. Med. 192:2000;1365-1372.
68. Masuya M., et al. The soluble Notch ligand, Jagged-1, inhibits proliferation of CD34+ macrophage progenitors. Int. J. Hematol. 75:2002;269-276.
69. de León A., et al. Design, characterization and application of a minibioreactor for the culture of human hematopoietic cells under controlled conditions. Cytotechnology. 28:1998;127-138.